Term ends Oct 16, 2032 · Medium confidence
20-year base term ends Oct 16, 2032
Why Medium: A parent in the chain could not be resolved.
Oct 16, 2012
Oct 16, 2032
Mar 24, 2020
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 16, 2012, when application PCT/US2012/060361, the earliest non-provisional in its chain, was filed (this one was filed Aug 22, 2018); a parent in its chain could not be resolved (the next row) | Oct 16, 2032 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 10,080,802) | resolves to Oct 16, 2032, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 16, 2032 | Medium confidence |
This family
| US 9,278,099 | In force Oct 2032 | Oct 2032 |
| US 10,080,802 | In force Oct 2032 | Oct 2032 |
| US 10,596,263 | this patent Oct 2032 | Oct 2032 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 17, 2019 Reel 50397, frame 283 | Campbell, Gossett Augustus; Richardson, Helen; Williams, Peter A. | Glaxo Wellcome Manufacturing Pte Ltd. | Assignment of Assignor's Interest |
| Sep 17, 2019 Reel 50397, frame 381 | Richardson, Helen; Williams, Peter A.; Campbell, Gossett Augustus | GlaxoSmithKline Intellectual Property Limited | Assignment of Assignor's Interest |
| Sep 17, 2019 Reel 50397, frame 492 | Glaxo Wellcome Manufacturing Pte Ltd. | GlaxoSmithKline Intellectual Property Limited | Assignment of Assignor's Interest |
| Sep 17, 2019 Reel 50397, frame 713 | Leo Osprey Limited | Novartis AG | Assignment of Assignor's Interest |
| Sep 17, 2019 Reel 50398, frame 351 | GlaxoSmithKline Intellectual Property Limited | Leo Osprey Limited | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 10,080,802, ends no earlier than this term, so it caps nothing.